A Naturalistic Two-year Cohort Study of Agitation and Quality of Life in Care Homes
MARQUE2
MARQUE (Managing Agitation and Quality of Life) Stream 2: A Naturalistic Two-year Cohort Study of Agitation and Quality of Life in Care Homes
1 other identifier
observational
1,734
1 country
1
Brief Summary
One third of the population, aged over 65, live and will die with dementia. Half of people with dementia experience symptoms of agitation every month. Symptoms of agitation include restlessness, pacing, shouting and verbal or physical aggression. Many people with agitation are admitted to care homes as families find they cannot care for them at home. Within the care home, staff also often find managing people with agitation difficult and they react in a wide range of ways. Agitated behaviour takes up staff time and emotional and physical energy but they do not always know how to respond. This study is one of the streams in an integrated programme to help tackle agitation in a variety of settings from domestic environments to end of life. Our primary hypothesis is that for people with dementia living in care homes, paid carer use of dysfunctional coping strategies predicts lower quality of life in residents with dementia and that this is more so at higher levels of agitation. We will recruit 60-80 care homes (residential or nursing homes). We will identify all residents with dementia, and the care home manager will approach them and their family carers. After obtaining informed consent, or advice from personal or nominated consultees for those lacking capacity, we will ask people with dementia who can answer questions about their quality of life using the DEMQOL. We will also ask staff and their family carers for those who have them, to rate the quality of life of the person with dementia using the DEMQOLproxy. We will ask care home staff other questions about residents with dementia, including about agitation, using the Cohen-Mansfield Agitation Inventory (CMAI), and the care they receive. Staff will also answer questions about the ways they cope with caring stresses, using the COPE. We will measure quality of life and agitation 5 times over 16 months. We will use our results to test our theory that agitation is an important factor determining residents quality of life, and that the ways staff cope with stress affect the impact agitation has on quality of life.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Apr 2014
Typical duration for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
April 1, 2014
CompletedFirst Submitted
Initial submission to the registry
August 4, 2014
CompletedFirst Posted
Study publicly available on registry
August 15, 2014
CompletedPrimary Completion
Last participant's last visit for primary outcome
August 1, 2016
CompletedStudy Completion
Last participant's last visit for all outcomes
December 1, 2016
CompletedDecember 4, 2015
May 1, 2015
2.3 years
August 4, 2014
December 3, 2015
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
DEMQOL and DEMQOL proxy
quality of life of the person with dementia
Up to 16 months
Secondary Outcomes (6)
Brief COPE (Coping Orientations to Problems Experienced)
baseline
Maslach burnout inventory
baseline
revised Modified Conflict Tactics Scale for professional carers
baseline
Cohen-Mansfield Agitation Inventory
0,4,8,12,16 months
Neuropsychiatric Inventory
0,4,8,12,16 months
- +1 more secondary outcomes
Other Outcomes (3)
EQ-5D proxy
0,4,8,12,16 months
hospitalisations and date and cause of death
up to 16 months
Therapeutic Environment Screening Survey for Nursing Homes and Residential Care (TESS-NH/RC)
0,4,8,12,16 months
Eligibility Criteria
We will recruit care homes from across England. Our sampling frame will encompass all care homes types where people with dementia reside to ensure external validity and generalisability. We will recruit homes to ensure a representation of each provider type (voluntary, state and private) care provision (nursing, residential) and of urban/suburban and rural locations. There are around 18,000 English care homes and 80% of residents have dementia (Alzheimer's Society). We will include all people with dementia diagnosed or screening positive for possible dementia on the Noticeable Problems checklist, all care home staff who provide care for this population and family carers who are in regular contact.
You may qualify if:
- We will also interview the consenting primary family carer of each resident included, if they see their relative at least monthly, and all consenting care team members, who provide hands-on care.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Care homes across England
London, United Kingdom
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Claudia Cooper
UCL
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
August 4, 2014
First Posted
August 15, 2014
Study Start
April 1, 2014
Primary Completion
August 1, 2016
Study Completion
December 1, 2016
Last Updated
December 4, 2015
Record last verified: 2015-05